RI
AQST icon

RTW Investments’s Aquestive Therapeutics AQST Stock Holding History

RTW Investments’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.8M Buy
7,426,471
+1,176,471
+19% +$4.77M 0.31% 55
2025
Q4 		$40.4M Hold
6,250,000
– – 0.4% 52
2025
Q3 		$34.9M Buy
+6,250,000
New +$27M 0.43% 48

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

RTW Investments's AQST Position: Q1 2026 in Review

RTW Investments increased its Aquestive Therapeutics (AQST) stake by 19% in Q1 2026, buying an estimated $4.77M and bringing the position to 7,426,471 shares worth $30.8M. The position accounts for 0.31% of the portfolio, ranked #55.

RTW Investments first reported a position in AQST in Q3 2025 and has held it in 3 quarters since. The position peaked at $40.4M in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • RTW Investments held 7,426,471 shares of Aquestive Therapeutics worth $30.8M as of Q1 2026.
  • RTW Investments bought 1,176,471 Aquestive Therapeutics shares in Q1 2026, an estimated $4.77M.
  • Aquestive Therapeutics made up 0.31% of RTW Investments's portfolio in Q1 2026, its #55 holding.
  • RTW Investments first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • RTW Investments's Aquestive Therapeutics position peaked at $40.4M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.